chemically-treated matrix, which lyses cells from a variety of tissue sources (e.g. blood, saliva, plant tissue). Upon immediate cell lysis the released DNA is bound within the supporting material, e.g. a card. The matrix protects nucleic acids from damaging agents (e.g. nucleases, oxidative agents and bacterial growth) which serves to reduce degradation. According to the manufacturer, even 22-year-old blood samples can yield short tandem repeat (STR) profiles commonly generated in forensic genetics [14] . However, most of these studies evaluated fresh blood samples which are applied immediately on the FTA cards, although other sample types also have been reported [11, [15] [16] [17] . Many of these studies have targeted forensically-relevant STR markers [18, 19] or single nucleotide polymorphisms (SNPs) [20] , and only few studies report the results from genome wide association studies [21] . DNA quality and quantity in PM samples with variable PM intervals (PMIs) stored on FTA paper have not tested to determine if such samples meet the demands of forensic or other genomic DNA analyses.
This study evaluates time-dependent DNA degradation and the ability to amplify STRs and a longer genomic target (i.e. the CYP2D6 gene) in PM blood samples on FTA cards stored up to 16 years. First, the internal sample variation was evaluated by comparing DNA yields obtained from three different spots of the same bloodstain sample. Sample-to-sample variation was evaluated in a similar manner. Second, the quality and quantity of recovered DNA as well as the level of inhibition associated with the DNA extracts were assessed. Finally, the effective DNA yield was evaluated by determining the amplification success of short and relatively large amplicons using forensic and pharmacogenetic genotyping applications, respectively.
Materials and methods
Blood samples stored on the FTA Gene cards were obtained from forensic autopsies performed in 1998-2013. Certified standardized procedures were implemented in all autopsy procedures, including the collection of PM blood and its application onto the FTA cards. The sampled cadavers showed variation in the peri-mortem pathophysiological condition and in the extent of PM changes. To evaluate the time-dependent DNA degradation four samples were selected at random from each of the eight evenly separated time points covering the entire storage period (Fig. 1a) .
DNA extraction and quantification
All reagents and instruments used were from Applied Biosystems (Foster City, CA, USA), Life Technology Corporation (Carlsbad, CA, USA), unless mentioned otherwise.
FTA cards were pierced with a Harris Micro-Punch TM -puncher (Ted Pella, Inc., Redding, CA, USA). Each FTA bloodstain sample was extracted in triplicate, using four (2.0 mm diameter) punches as input material for each extraction (Fig. 1b) . To avoid crosscontamination, the tip of the puncher was cleaned between samples by piercing clean filter paper multiple times.
The bloodstain discs were lysed according to the manufacturer's protocol using PrepFiler Express TM Forensic DNA Extraction 
Evaluation of the amplification success
To measure the practical effect of degradation, amplification success of two types of autosomal loci, differing in length, was analyzed. Amplification of short fragments was assessed with GlobalFiler 1 , a forensic STR multiplex assay (75-444 bp amplicons), and long fragments with amplification of a 5.1 kb genomic CYP2D6 gene fragment.
STR analysis

GlobalFiler
1 multiplex assay, which amplifies 21 autosomal STR loci, two Y chromosomal markers (DYS391, Y indel) and one sex determining marker (Amelogenin), was performed according to the manufacturer's protocol, except that the reaction volume (7.5 ml) and 25 PCR cycles used. These amplification conditions have been validated in our laboratory and are part of the accredited method. Amplified DNA fragments were separated by capillary electrophoresis using a 24-capillary 3500xL Genetic Analyzer, polymer 4 (POP-4 TM ) and HID36_POP4xl Run Module. Samples were run along with 500LIZ TM dye size standard. Data analysis was performed with GeneMapper 1 ID-X ver. 1.4 software. For allele calling, 400 relative fluorescence units (rfu) were used as a peak amplitude threshold, and the fragment sizes were called using the ''Local Southern'' sizing method.
The STR-data was analyzed by comparing allele peak heights observed in the FTA samples with those obtained for samples of good quality, i.e. the positive control. Peak heights of the two heterozygotic peaks were summed. For the analysis, the loci were assigned relatively evenly into four size categories based on the average amplicon size: <130 bp (D3S1358, D2S441, D19S433, D22S1045, D10S1248, D8S1179), 130-200 bp (D1S1656, vWA, TH01, D5S818), 200-300 bp (D16S539, D21S11, D13S317, D7S820, D12S391), and >300 bp (CSF1PO, TPOX, D18S51, FGA, SE33, D2S1338). For each sampling time point, the average of all peak heights observed within a size class was then compared with the average peak heights observed in two independent PCRs of the positive control (DNA Control 007).
CYP2D6 analysis
To evaluate the integrity of longer DNA fragments the pharmacogenetically interesting CYP2D6 gene was chosen. CYP2D6 gene is part of the large CYP2D cluster which is formed together with two pseudogenes, CYP2D7 and CYP2D8P [23] . To exclude the highly homologous pseudogenes from the target of interest, the CYP2D6 gene (5.1 kb) was amplified using a previously described protocol [24] with slight modifications to the reaction mixture. Primer sequences used in this reaction were described by Lundqvist et al. [25] . The 25 ml reaction mixture included 1.0 U Cycling conditions were the same as those described by Sistonen et al. [24] . Amplification success of the CYP2D6 gene was verified with the 2100 Bioanalyzer Instrument using the DNA 7500 kit and 2100 Expert Software for the data analysis (Agilent Technologies).
Statistical analyses
To measure the effect of storage time on DNA yield, harmonic means of DNA concentrations from each year were plotted against the storage time. As with the DNA concentrations, the DI values were plotted against the storage time. DI values also were plotted against PMIs. With all variables the statistical significance of correlation was assessed using Pearson Correlation Coefficient. All statistical analyses were performed with IBM SPSS Statistics ver. 22 (IMB corp. 2013, Armonk, NY, USA) software.
Results and discussion
Generally, our study confirms the previously established observations of robust and reliable DNA recovery from blood samples stored on FTA for long time periods [14] . In addition, DNA recovery from PM blood samples, with variable initial PMIs, is feasible from samples stored on FTA cards. However, our study indicates that genomic studies which require large amounts of well-preserved DNA may not be possible with long term FTA stored blood samples. The quality and quantity of the DNA recovered decreased over time to the extent that large-amplicon targets may no longer be amplified. Chemical treatment within the FTA cards [26] and dry storage conditions may not be sufficient for maintaining the integrity of relatively long DNA fragments.
Internal and sample-to-sample variation; sample triplicates
The DNA concentration ranged from 1.50 to 43.64 ng/ml with a mean of 10.95 AE 8.19 ng/ml ( Table 1 ). The amount of the input FTAmaterial was equal (four 2 mm punches/extraction), and each sample was extracted in triplicate. Yet variation was observed in DNA concentrations both within and among the samples. Some variation is expected with any sample manipulation. However, as the extraction method used is proven to be rather effective [12, 13] , high internal variation among triplicates (SD values between 0.26 to 16.07) suggests that PM changes, e.g. blood clotting prior to sampling as well as ante-mortem pathophysiological conditions of the deceased, can affect DNA recovery. Many factors, such as hemoglobin [10] , hematocrit and viscosity of blood [27] and an individual's white blood cell count at the time of sampling [28] create variability in bloodstain samples. It is expected that, e.g. viscosity of blood will change post-mortem. While the intention of taking multiple punches for extraction was to reduce sampling variance, it is recommended to ensure sufficient DNA yield that multiple bloodstain discs be used per extraction (at least with the 2 mm diameter punches used in this study).
Storage time and DNA quantity and quality; pooled samples
Re-quantification results of pooled samples were similar to the mean concentration of the corresponding triplicates (data not shown) except for one sample (sample 2, 2004) where concentration of the pooled sample was lower than what was expected based of the mean concentration of triplicates. The reason for this observation is unknown, but pipetting error may be a plausible explanation.
Quantification results from the pooled samples indicate that (1) the DNA concentration is diminished over storage time; and (2) DNA degradation is increased over storage time (Fig. 2) . These observations were evaluated with the Pearson correlation coefficient. A significant negative correlation was observed between FTA storage time and DNA quantity at the 0.01 level (r = À0.836), and a a One of the parallel samples was excluded from the quantification measurement, because the sample evaporated from the tube due to cap malformation. Results are from two parallel samples instead of three. significant positive correlation (r = 0.738 at the level 0.01) between FTA storage time and degradation level. The mean value for the DI was 0.97 AE 0.29. To highlight the decreasing trend of sample concentrations the effect of outliers was diminished by using harmonic means of DNA concentrations. The effect of variable PMIs to DI was evaluated, but no correlation between these parameters was observed (data not shown). As the longest PMI in this study was only 13 days, it is likely that the environmental conditions during the PMI affected DNA integrity more than the PMI time itself. However, when the PMI exceeds the 13 days the time could become a factor; but this effect could not be investigated with the current samples. In addition, no inhibition (mean C t -value 27.70 AE 0.36) was observed in this study (data not shown). Samples with high DNA concentration show a slight increase in C t -values. However, this observation is more likely attributed to competition for reagents between the sample and the IPC than to inhibiting factors. Although in general IPC gives a rather good indication of possible PCR inhibition, normal C t -values of IPC around 27 cycles cannot totally exclude possible inhibition in extracts by PCR inhibitors not affecting IPC C t -values.
Effects of degradation in STR and CYP2D6 analysis
The effect of storage time on DNA degradation was clearly visible in the functional studies of STR and CYP2D6 gene analyses. The 21-loci STR profiles demonstrate clearly an increasing trend of degradation towards the older samples (Fig. 3) . The shorter fragments amplify better than the longer fragments in samples of all ages, but the differences between the amplification success of the short to long fragments diminishes substantially with shorter storage times (ranging from 56 to 7% units between 1998 and 2013, respectively). This can be taken as a clear indication of DNA fragmentation over time. Interestingly, the relative amplification success of the shorter fragment is better in the old than in the more recently stored samples. This observation could be explained by diminished competition of reagents (nucleotides, polymerase) during the PCR in absence of longer fragments. Notably, however, full STR-profiles were obtained from all samples despite the decreasing peak height with storage time.
In contrast, amplification of the larger 5.1 kb autosomal fragment could not be accomplished for some samples (those with a DI >1) (Fig. 4) . In some cases the amplification failed even for samples with DI < 1. This finding is likely due to the large size difference between the longest amplicon of the Quantifiler 1 HP-kit (214 bp) and the 5.1 kb autosomal fragment. In the case of the 5.1 kb fragment tested here, the general guideline of DI > 1 as a fragmentation threshold appeared to work well, but when different size fragments are tested the threshold is likely different and should be empirically determined.
Conclusions
It is expected that PM changes prior to sampling can create notable variation in DNA quality. In addition, DNA yield may vary from sample-to-sample, depending on the white blood cell count in an individual's blood determined by the ante-mortem pathophysiological condition of the person and the PMI. As many of the factors affecting the DNA stored on the FTA cards are unknown, it is difficult, if not impossible, to predict the quality and quantity of the DNA remaining in individual samples without proper quantification.
There are some limitations to this study that should be considered. There are no control samples in the strict sense as such a study was not perceived at the time of collection of the samples especially the longest time stored samples. In order to have truly informative controls, an aliquot of the post-mortem blood sample should have been typed immediately after death (or autopsy), using the same extraction method and STR kit as for the FTA sample 16 years later. That requirement would not be feasible given the rapid development of forensic genetics techniques over the years. Any other preservation method for the sample (such as freezing) to maintain a control to compare with a FTA stored samples would also affect integrity.
As no inhibition was detected in the samples the most reasonable explanation for the amplification differences observed in this study is degradation which increases over storage time. According to our results, bloodstained FTA cards contain sufficient amounts of DNA for human identification purposes when highly sensitive STR typing is used. Obtaining sufficient intact DNA for large scale genomic studies may be more difficult. This problems created by loss of high quality DNA may be overcome, e.g. by genome wide amplification (GWA) prior to targeted PCR, as reported for large scale SNP analyses by Fowler et al. (2012) [21] .
When planning experiments with relatively long amplicons, the effect of degradation must be considered and tested. Quantification indices describing concentration, degradation and inhibition provide useful tools to predict success, but the meaningful threshold values must be established specifically for different types of studies.
